How do Growth Factors Stimulate Cell Division?

G-Protein Coupled Receptor Pathway

Type G_salpha

Growth factors bind to GPCRs linked to G_s protein. This stimulates G_salpha, which then activates adenylate cyclase (AC). Adenylate cyclase converts ATP to cyclic AMP. cAMP actives protein kinase A (PKA), which affects transcription factors that increase transcription of the proto-oncogenes. Proto-oncogenes transcription moves the cell from the G1 phase to the S phase.

Type G_qalpha

The G-Protein Coupled Receptor Pathway involves growth factors binding to GPCRs, especially those containing G_q protein. This activates G_q, which in turn stimulates phospholipase C. Phospholipase C converts PIP2 to DAG and IP3. DAG promotes protein kinase C (PKC), which activates transcription factors or other enzymes that stimulate proto-oncogenes. IP3 releases calcium, which binds to calmodulin. The calcium-calmodulin complex activates kinases, which then trigger transcription factors or enzymes involved in proliferation activation.

Tyrosine Kinase Receptor Pathway

Growth factors bind to tyrosine kinase receptors, causing dimerization and phosphorylation of tyrosine residues. This activates the Grb-2 protein, which then activates the SOS protein. The SOS activates Ras, a GTPase. Activated Ras activates Raf, which then activates a cascade of kinases, leading to the activation of transcription factors that move to the nucleus and induce TF-2, which stimulates cycling and CDK genes. Binding cycling and CDK together releases E2F from the RB protein. E2F induces proto-oncogene transcription and moves cells from the G1 phase to the S phase of the cell cycle.

Janus Kinase Receptor Pathway

Growth factors bind to Janus kinase receptors, leading to receptor dimerization and the phosphorylation of tyrosine residues. This recruits inactive STAT proteins, and then its tyrosine residue is phosphorylated by JAK. Active STAT proteins move to the nucleus, leading to the activation of transcription factors that move to the nucleus and induce TF-2, which stimulates cycling and CDK genes. Binding cycling and CDK together releases E2F from the RB protein. E2F induces proto-oncogene transcription and moves cells from the G1 phase to the S phase of the cell cycle.

In Conclusion, growth factors trigger cell proliferation through diverse signaling pathways, including GPCR, RTK, and JAK-STAT. Despite their structural differences, these pathways share a fundamental objective: activating nuclear transcription factors. These factors drive the expression of cyclins and proto-oncogenes, ultimately neutralizing cell cycle inhibitors like Rb and propelling the cell toward division. Understanding these integrated networks is crucial, as their dysregulation is a hallmark of oncogenesis and various hyperproliferative diseases.

Reference:

1. Franke, T. F. (2008). PI3K/Akt: Getting it right matters. Oncogene, 27(50), 6473–6488. https://doi.org/10.1038/onc.2008.313
2. Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007). MAP kinase signaling pathways in cancer. Oncogene, 26(22), 3279–3290. https://doi.org/10.1038/sj.onc.1210421
3. Abbas et al Cell Mol Imm 2015 Elsevier
4. Figel, S., & Fenstermaker, R. A. (2018). Cell-Cycle Regulation. In Elsevier eBooks (pp. 257–269). https://doi.org/10.1016/b978-0-12-812100-9.00018-8
5. Biorender.com